Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Stroke. 2018 Nov;49(11):2652–2658. doi: 10.1161/STROKEAHA.118.021799

Table 4.

Oral Anticoagulation Resumption, CHA2DS2-VASc Score and Recovery after Intracerebral Hemorrhage

CHA2DS2-VASc Score OAT Association with Functional Recovery* OAT Association with mRS Score Change**
OR OR
95% CI
p OR OR
95% CI
p
0 – 2 0.69 0.36 – 1.32 0.27 0.70 0.35 – 1.40 0.32
3 – 4 1.33 0.99 – 1.79 0.061 1.11 1.00 – 1.24 0.061
5 – 6 1.98 1.14 – 3.44 0.016 1.49 1.07 – 2.07 0.018
7 – 9 2.55 1.16 – 5.59 0.021 1.95 1.19 – 3.18 0.008

All analyses adjusted for discharge modified Rankin scale, ICH location, and exposure to antiplatelet agents.

*

defined as achieving mRS ≤3 if mRS > 3 at discharge

**

difference in mRS score between one-year follow-up and discharge, effect size calculated for one-point decrease in mRS

Abbreviations: 95% CI = 95% Confidence Interval, mRS = modified Rankin Scale, OAT = Oral Anticoagulation Treatment, OR = Odds Ratio, SE = Standard Error